CL 82198 hydrochlorideSelective MMP-13 inhibitor CAS# 307002-71-7 |
- Narciclasine
Catalog No.:BCN4732
CAS No.:29477-83-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 307002-71-7 | SDF | Download SDF |
| PubChem ID | 16760373 | Appearance | Powder |
| Formula | C17H23ClN2O3 | M.Wt | 338.83 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 100 mg/mL (330.72 mM; Need ultrasonic) | ||
| Chemical Name | N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide;hydrochloride | ||
| SMILES | C1COCCN1CCCCNC(=O)C2=CC3=CC=CC=C3O2.Cl | ||
| Standard InChIKey | PIOACXKZWXHBRB-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H22N2O3.ClH/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19;/h1-2,5-6,13H,3-4,7-12H2,(H,18,20);1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | CL-82198 is a selective inhibitor of MMP-13.
In vitro: In the presence of 10 and 20 μM of the specific MMP-13 inhibitor, CL-82198, migration of the LS174 cells was significantly reduced by 55 and 52%, respectively. . CL-82198 binds to the S1' pocket of MMP-13 leading to 89% enzyme inhibition at a concentration of 10 μg/ml. The addition of the specific MMP-13 inhibitor CL-82198 at a concentration of 10 μM resulted in a 45±5.6% reduction in the migration of LS174 cells. References: | |||||
CL 82198 hydrochloride Dilution Calculator
CL 82198 hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9513 mL | 14.7567 mL | 29.5133 mL | 59.0267 mL | 73.7833 mL |
| 5 mM | 0.5903 mL | 2.9513 mL | 5.9027 mL | 11.8053 mL | 14.7567 mL |
| 10 mM | 0.2951 mL | 1.4757 mL | 2.9513 mL | 5.9027 mL | 7.3783 mL |
| 50 mM | 0.059 mL | 0.2951 mL | 0.5903 mL | 1.1805 mL | 1.4757 mL |
| 100 mM | 0.0295 mL | 0.1476 mL | 0.2951 mL | 0.5903 mL | 0.7378 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
IC50: 89% inhibition at 10μg/mL
CL 82198 is a selective MMP-13 inhibitor.
Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular matrix associated with normal tissue remodeling processes such as wound healing, pregnancy, and angiogenesis. Expression and activity of MMPs is highly controlled due to their degradative nature where the apparent loss in this regulation leads to the pathological destruction of connective tissue and the ensuing disease state.
In vitro: CL-82198 was identified as a weak inhibitor against MMP-13 and demonstrated no activity against MMP-1, MMP-9, or the related enzyme TACE. Bearing drug-like properties, CL-82198 was regarded as an ideal candidate for optimization of enzyme potency and selectivity. In NMR binding studies, it was shown that CL-82198 bound within the entire S1’ pocket of MMP-13, which was the basis of its selectivity against MMP-1, MMP-9, and TACE [1].
In vivo: To investigate the contribution of MMP-13 down-regulation during gastroprotection by acetaminophen, the effects of CL-82198 on IBP-induced gastric damage were evaluated. Results showed that CL-82198 decreased gastric lesions in a dose-dependent manner in the presence of IBP. Compared with IBP administration alone, CL-82198 administered at 0.2 and 1.0 mg/kg resulted in 40.3% and 72.1% decrease in gastric lesion, respectively [1].
Clinical trial: N/A
References:
[1] James M. Chen,Frances C. Nelson,Jeremy I. Levin,Dominick Mobilio,Franklin J. Moy,Ramaswamy Nilakantan,Arie Zask,andRobert Powers. Structure-Based Design of a Novel, Potent, and Selective Inhibitor for MMP-13 Utilizing NMR Spectroscopy and Computer-Aided Molecular Design. J. Am. Chem. Soc.,2000,122(40), pp 9648–9654
[2] Fukushima E,Monoi N,Mikoshiba S,Hirayama Y,Serizawa T,Adachi K,Koide M,Ohdera M,Murakoshi M,Kato H. Protective effects of acetaminophen on ibuprofen-induced gastric mucosal damage in rats with associated suppression of matrix metalloproteinase. J Pharmacol Exp Ther.2014 Apr;349(1):165-73.
- GW-1100
Catalog No.:BCC1610
CAS No.:306974-70-9
- IBC 293
Catalog No.:BCC7376
CAS No.:306935-41-1
- TCID
Catalog No.:BCC4449
CAS No.:30675-13-9
- 5-Methoxy-7-hydroxycoumarin
Catalog No.:BCN3538
CAS No.:3067-10-5
- Cycloolivil
Catalog No.:BCN4081
CAS No.:3064-05-9
- (20S)-Protopanaxdiol
Catalog No.:BCN1254
CAS No.:30636-90-9
- AVE 0991 sodium salt
Catalog No.:BCC4222
CAS No.:306288-04-0
- 2,2-Diphenylglycine
Catalog No.:BCC8496
CAS No.:3060-50-2
- Spermine tetrahydrochloride
Catalog No.:BCC6864
CAS No.:306-67-2
- Homovanillic acid
Catalog No.:BCN1253
CAS No.:306-08-1
- SC 79
Catalog No.:BCC6246
CAS No.:305834-79-1
- 3,9-Bis(2-cyanoethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane
Catalog No.:BCC8599
CAS No.:3058-04-6
- WAY 170523
Catalog No.:BCC2380
CAS No.:307002-73-9
- 1,4-Bis[2-(4-methyl-5-phenyloxazolyl)]benzene
Catalog No.:BCC8425
CAS No.:3073-87-8
- Troxipide
Catalog No.:BCC4744
CAS No.:30751-05-4
- CFTRinh-172
Catalog No.:BCC4419
CAS No.:307510-92-5
- SMER 28
Catalog No.:BCC7908
CAS No.:307538-42-7
- STF 083010
Catalog No.:BCC6209
CAS No.:307543-71-1
- Crosemperine
Catalog No.:BCN2074
CAS No.:30785-56-9
- [Des-octanoyl]-Ghrelin (rat)
Catalog No.:BCC5953
CAS No.:307950-60-3
- beta-Anhydrouzarigenin
Catalog No.:BCN5222
CAS No.:3080-20-4
- L-Theanine
Catalog No.:BCN2571
CAS No.:3081-61-6
- AEBSF.HCl
Catalog No.:BCC1219
CAS No.:30827-99-7
- 4-Oxododecanedioic acid
Catalog No.:BCN5223
CAS No.:30828-09-2
Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro.[Pubmed:11410791]
Oncol Rep. 2001 Jul-Aug;8(4):821-4.
Recently, we reported that cycloprodigiosin hydrochloride (cPrG.HCl), a novel H+/Cl- symporter, induces acidification of the cytosol and leads to apoptosis on rat and human liver cancer cells. In the present study, the effects of cPrG.HCl, a H+/Cl- symporter, were examined in colon cancer cell lines in vitro. In the MTT assay, cPrG.HCl inhibited the growth of two colon cancer cell lines (WiDr and SW480) in a dose- and time-dependent manner. The cPrG.HCl treatment of both types of cells induced apoptosis as confirmed by the appearance of a sub-G1 population and intranucleosomal DNA fragmentation. In addition, cPrG.HCl lowered pHi (below pH 6.8) respectively. Therefore, these results suggest that cPrG.HCl may be useful for the treatment of colon cancer cells.
DFT Studies of NH-Cl Hydrogen Bond of Amino Acid Hydrochloride Salts in Ion Channels.[Pubmed:27333545]
Acta Chim Slov. 2016;63(2):241-50.
Quantum chemical calculations were made, to study NH-Cl hydrogen bonds of two amino acid hydrochloride salts called alanine and threonine. The Nuclear Magnetic Resonance and Nuclear Quadrupole Resonance parameters for nitrogen and chlorine were calculated via four functionals such as, B3LYP, M062X, M06L, and CAM-B3LYP and by applying the 6-311++G(d,p) basis set. One of the functionals produced more accurate results. Geometry optimization was performed using the M062X/6-31++G(d,p) method, and Natural Bond Orbitals analysis was performed by applying the M062X/6-311++G(d,p) level. This study examined Nuclear Magnetic Resonance and Nuclear Quadrupole Resonance parameters with changes in structure from monomer to pentamer and investigated correlations between Natural Bond Orbitals parameters and Nuclear Magnetic Resonance or Nuclear Quadrupole Resonance parameters. The Natural Bond Orbitals parameters were used to investigate changes in structural parameters along with crystal development.
Utilization of 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) for kinetic spectrophotometric assay of befunolol hydrochloride in its pharmaceutical formulation.[Pubmed:16792064]
J AOAC Int. 2006 May-Jun;89(3):646-50.
A simple, accurate, precise, and sensitive kinetic spectrophotometric method for determination of befunolol hydrochloride is described. The method is based on the formation of a colored product with 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) in methanol at 70 degrees C for 45 min. The red-colored product was measured at 523 nm. The optimization of various experimental conditions is described; Beer's law was obeyed in the range 15.25 x 10(-6) to 122.04 x 10(-6) M. The results obtained showed good recoveries (100.1 +/- 0.80%). Application of the proposed method to a pharmaceutical formulation was successfully achieved. The determination of befunolol hydrochloride by fixed time, fixed concentration, and rate constant methods was feasible with the calibration equation obtained. However, the fixed time method proved to be more applicable.
Synthesis and physic-chemical properties of a copper(II) complex with 2-(2-pyridyl)iminotetrahydro-1,3-thiazine hydrochloride-water (1/2) (PyTzHCl.2H2O). Crystal structure of PyTz and [[CuCl(PyTz)]2(mu-Cl)2].[Pubmed:14659628]
J Inorg Biochem. 2004 Jan;98(1):15-23.
The synthesis of 2-(2-pyridyl)iminotetrahydro-1,3-thiazine (PyTz) has been carried out, as well as the determination of its X-ray crystal structure, together with the coordination behaviour and equilibra study of PyTzHCl.2H2O with copper(II) in aqueous solution at 298 K and 0.1 M ionic strength in NaClO4. The formation constants are determined and discussed in terms of the characteristics of the ligand. The compound Di-mu-chloro-bis[chloro[2-(2-pyrydil-kappaN)amino-5,6-dihydro-4H-1,3-thiazine-kap paN]copper] has been isolated and its crystal and molecular structure determined by X-ray analysis. The structure consists of dimeric molecules [Cu2Cl4L2], in which copper ions are bridged by two chloro ligands. The geometry about each copper approximates to a distorted square pyramid with the bridging ligands occupying apical and equatorial sites of each copper ion, while the PyTz ligand and the remaining chloride ion are located in an equatorial plane. The compound was also characterized through elemental analysis, magnetic susceptibility, electron paramagnetic resonance, and electronic and infrared spectroscopies.
